SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-407836
Filing Date
2014-11-12
Accepted
2014-11-12 07:39:20
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d781356d10q.htm 10-Q 666807
2 EX-31.1 d781356dex311.htm EX-31.1 7805
3 EX-31.2 d781356dex312.htm EX-31.2 7779
4 EX-32.1 d781356dex321.htm EX-32.1 4121
5 EX-32.2 d781356dex322.htm EX-32.2 4081
  Complete submission text file 0001193125-14-407836.txt   4146230

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnce-20140930.xml EX-101.INS 522495
7 XBRL TAXONOMY EXTENSION SCHEMA cnce-20140930.xsd EX-101.SCH 36366
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnce-20140930_cal.xml EX-101.CAL 58268
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnce-20140930_def.xml EX-101.DEF 129723
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnce-20140930_lab.xml EX-101.LAB 337158
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnce-20140930_pre.xml EX-101.PRE 253107
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 141211097
SIC: 2834 Pharmaceutical Preparations